✦ LIBER ✦

6083 Final results from PRECEPT: efficacy and safety of second-line treatment with panitumumab and FOLFIRI in patients with metastatic colorectal cancer (mCRC)

✍ Scribed by Cohn, A.; Smith, D.A.; Neubauer, M.A.; Richards, D.; Watkins, D.L.; Zhang, K.; Yassine, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

14LBA Randomized phase 3 study of panitu

✍ M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and efficacy of second-line treat

✍ Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 253 KB

Combining bevacizumab and panitumumab wi

✍ Liang, Hong-Liang; Hu, Ai-Ping; Li, Sen-Lin; Liu, Ji-Yong 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 195 KB

6132 POSTER Efficacy of Panitumumab Plus

✍ Price, T.; Peeters, M.; Strickland, A.; Ciuleanu, T.E.; Scheithauer, W.; O'Reill 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The Efficacy and Safety of Panitumumab A

✍ Edith P. Mitchell; Bilal Piperdi; Mario E. Lacouture; Heather Shearer; Nicholas 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 356 KB

A retrospective observational study on t

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB